Hinge Health Inc. (HNGE) vs 10x Genomics (TXG)
Hinge Health Inc. and 10x Genomics are both Health Information Services companies. 10x Genomics is the larger, with a market value of $11.1B against $7.4B — 1.5× the size. 10x Genomics has negative trailing earnings, so its P/E is not meaningful; Hinge Health Inc. trades at 70.8×. Hinge Health Inc. grew revenue faster over the last twelve months: 58.8% against −4.28%. Hinge Health Inc. has the higher net margin (14.9% vs −12.2%) and the higher return on invested capital (0.00% vs −20.2%). Across the 17 metrics below, Hinge Health Inc. leads on 14 and 10x Genomics on 3.
Valuation
Profitability
| Metric | HNGE | TXG | Health Information Services median |
|---|---|---|---|
| Gross margin | 84.49% | 70.03% | 63.38% |
| Operating margin | 13.01% | (14.33%) | (8.35%) |
| Net margin | 14.91% | (12.18%) | (14.70%) |
| Free cash flow margin | 39.43% | 19.68% | 0.58% |
| Return on equity | 41.44% | (9.40%) | (6.82%) |
| Return on assets | 14.12% | (7.47%) | (6.02%) |
| Return on invested capital | 0.00% | (20.20%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack